Correspondence 0001628280-24-008614 from Nautilus Biotechnology, Inc. (NAUT) (CIK 0001808805) (NAUT)
Nautilus Biotechnology, Inc. (NAUT) (CIK 0001808805)
Date: March 4, 2024 · CIK: 0001808805 · Accession: 0001628280-24-008614
AI Filing Summary & Sentiment
File numbers found in text: 333-277437
Letter
Document
March 4, 2024
VIA EDGAR
U.S. Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, D.C. 20549-3720
Attention: Jessica Ansart
Re: Nautilus Biotechnology, Inc.
Registration Statement on Form S-3
Filed on February 28, 2024
File No. 333-277437
Acceleration Request
Requested Date: March 6, 2024
Requested Time: 4:00 p.m. Eastern Time, or as soon thereafter as practicable
Ladies and Gentlemen:
Pursuant to Rule 461 under the Securities Act of 1933, as amended, Nautilus Biotechnology, Inc. (the “Company”) hereby requests that its Registration Statement on Form S-3 (File No. 333-277437) (the “Registration Statement”) be declared effective at the “Requested Date” and “Requested Time” set forth above or at such later time as the Company or its counsel may orally request via telephone call to the staff of the Division of Corporation Finance of the Securities and Exchange Commission. Once the Registration Statement has been declared effective, please orally confirm that event with our counsel, Wilson Sonsini Goodrich & Rosati, P.C., by calling Zachary B. Myers at (858) 350-2350.
Sincerely,
NAUTILUS BIOTECHNOLOGY, INC.
Show Raw Text
CORRESP 1 filename1.htm Document March 4, 2024 VIA EDGAR U.S. Securities and Exchange Commission Division of Corporation Finance 100 F Street, N.E. Washington, D.C. 20549-3720 Attention: Jessica Ansart Re: Nautilus Biotechnology, Inc. Registration Statement on Form S-3 Filed on February 28, 2024 File No. 333-277437 Acceleration Request Requested Date: March 6, 2024 Requested Time: 4:00 p.m. Eastern Time, or as soon thereafter as practicable Ladies and Gentlemen: Pursuant to Rule 461 under the Securities Act of 1933, as amended, Nautilus Biotechnology, Inc. (the “Company”) hereby requests that its Registration Statement on Form S-3 (File No. 333-277437) (the “Registration Statement”) be declared effective at the “Requested Date” and “Requested Time” set forth above or at such later time as the Company or its counsel may orally request via telephone call to the staff of the Division of Corporation Finance of the Securities and Exchange Commission. Once the Registration Statement has been declared effective, please orally confirm that event with our counsel, Wilson Sonsini Goodrich & Rosati, P.C., by calling Zachary B. Myers at (858) 350-2350. Sincerely, NAUTILUS BIOTECHNOLOGY, INC. By: /s/ Sujal Patel Sujal Patel President and Chief Executive Officer cc: Anna Mowry, Nautilus Biotechnology, Inc. Matthew Murphy, Nautilus Biotechnology, Inc. Zachary B. Myers, Wilson Sonsini Goodrich & Rosati